U.S. markets close in 3 hours 21 minutes

Novartis AG (NVS)

NYSE - Nasdaq Real Time Price. Currency in USD
97.05+0.05 (+0.05%)
As of 12:39PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close97.00
Bid96.93 x 900
Ask96.95 x 800
Day's Range96.49 - 97.20
52 Week Range79.98 - 105.61
Avg. Volume1,481,244
Market Cap199.482B
Beta (5Y Monthly)0.51
PE Ratio (TTM)25.14
EPS (TTM)3.86
Earnings DateN/A
Forward Dividend & Yield3.50 (3.61%)
Ex-Dividend DateMar 09, 2023
1y Target Est112.75
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Near Fair Value
5% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for NVS

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Novartis AG
    Analyst Report: Novartis AGNovartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
    Fair Value
    Economic Moat
    22 hours agoMorningstar
View more